Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

New hair perming method using tyrosine is gentler and can be done with a blow-dryer.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Botulinum toxin injections do not help with male pattern baldness.

Higher CSF 5-HIAA levels may predict better response to serotonin re-uptake inhibitors in trichotillomania.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Biomimetic peptides improved hair growth and increased growth factors in hair follicles for hair loss patients.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Teak seed extract is safe and reduces pain in mice.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.